Valeant says Allergan falsely stated that Valeant’s Bausch + Lomb pharmaceutical sales were stagnant or declining, despite growing about 6 per cent in the second quarter
BERTRAND MAROTTE, The Globe and Mail
Mon, 07/21/2014 - 4:46am
Valeant says Allergan falsely stated that Valeant’s Bausch + Lomb pharmaceutical sales were stagnant or declining, despite growing about 6 per cent in the second quarter